Initial Submission – Sponsor/CROs

Welcome to the Quorum Review IRB initial submission process. To allow adequate time for preparation and review, Quorum IRB requires that protocol submission materials be received at least one week in advance of the review Board meeting at which they will be discussed. 


Board meetings to review new protocols are held each Tuesday, Wednesday and Friday, excluding holidays. Our Wednesday meeting includes review of research at Canadian study sites; read more about our North American Review Ethics Board.


Quorum IRB has four different types of clinical research study submissions, each with its own path and unique set of requirements. Please click on your type of clinical research study below to access forms, FAQs and submission guidance that should assist with any questions from sponsors and CROs alike.

Central Studies

In this case, Quorum is the designated central IRB for the study. Quorum IRB communicates with the sponsor / CRO, and protocol level decisions are made by the sponsor / CRO on behalf of research study site(s).

Single Site Studies

An investigator may choose Quorum Review IRB even If the sponsor or CRO has not designated Quorum as the central ethics review Board for the research study. Quorum Review IRB characterizes this arrangement as a “single site” study. 

Observational and Minimal Risk Registries

Quorum Review IRB offers a simplified process for studies that qualify for Quorum’s “Observational Registry” designation. To qualify for this process, a protocol should not involve any interventions that are greater than minimal risk specifically for the research. 

Investigator Generated Studies

Quorum Review IRB reviews clinical research generated by individual investigators conducting research studies and has a separate set of forms for these studies.

   
HII